透過您的圖書館登入
IP:3.22.119.251
  • 期刊
  • OpenAccess

人工晶體水疱性角膜病變之治療

Treatment of Pseudophakic Bullous Keratopathy

摘要


九位人工晶體水疱性角膜病變的病例,所放置的人工晶體五例是前房型,四例是後房型,其中八例進行角膜移值手術,一例open-sky將前房人工晶體取出,未更換角膜。在八例角膜移植手術過程中,將兩例前房型人工晶體摘除,換成後房型人工晶體並將它們縫合固定於虹彩上,六例人工晶體保留原位(前房型兩例,後房型四例),手術後七例(7/8)角膜保持清澈,視力從0.1至0.5不等,一例有角膜潰瘍,視力不及0.1,兩例有繼發性青光眼,它們經過治療後病況均已控制。角膜移植是人工晶體水疱性角膜病變唯一有效治療方法。

關鍵字

無資料

並列摘要


There were 9 cases pseudophakic bullous keratopathy (5 AC-IOL and 4 PC-IOL) of which 8 cases underwent penetrating keratoplasty, and the other one only received open-sky to remove the AC-IOL. Two cases from the eight above the AC-IOL were removed then were replaced with the iris-sutured PC-IOL. As to the rest six cases (2 AC-IOL and 4 PC-IOL) retained their IOL. Both situations were undergone when the penetrating keratoplasty being performed. During the average follow-up period of eight months after the surgery, corneal graft remained clear in 7 cases (7/8) with the visual acuity ranging from 0.1 to 0.5. But 2 out of the eight developed secondary glaucoma (2/8), corneal ulcer was discovered after cryotherapy for reducing the elevated IOP in one case although. Nevertheless, these two postoperative complications were under control Therefore, penetrating keratoplasty is the only treatment for pseudophakic bullous keratpathy.

被引用紀錄


陳偉勵(2005)。眼角膜手術之臨床與基礎相關研究〔博士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2005.00616

延伸閱讀